Jo Henderson was seventeen years old and experiencing months of stomach pain, bloating, and constipation when she received a diagnosis of advanced colorectal cancer, a condition that is exceptionally rare in patients under twenty. According to nbcnews.com, cases in this youngest cohort represent about one in a million individuals and account for fewer than one hundred diagnoses annually in the United States. While overall rates of colorectal cancer are climbing among adults under fifty—with individuals born in the 1990s facing four times the risk compared to those born in the 1960s—new findings reveal that pediatric and adolescent cases frequently present with aggressive tumor characteristics and advanced disease stages.
Study Tracks Adolescent Colorectal Cancer Cases Diagnosed Between 2012 and 2023
To investigate the clinical characteristics of early-onset disease, researchers analyzed medical records from the Pediatric Surgical Oncology Research Collaborative, a network of North American centers tracking children with cancer. As reported by gizmodo.com, the study identified eighty-four patients aged twenty-one and younger who received a colorectal cancer diagnosis between 2012 and 2023. The median age of patients in the cohort was 16.5 years, and the median duration of symptoms before official diagnosis reached twelve weeks.
Dr. Danielle Cameron, director of pediatric surgical oncology at Mass General Brigham Cancer Institute in Boston and a co-author of the research, stated that adolescents and young adults represent a uniquely vulnerable population facing severe risks for poor outcomes and frequent diagnostic delays. The findings are scheduled to be presented at the American Academy of Pediatrics national conference in San Diego. The study authors specifically focused on sporadic cases where patients possessed no known genetic predisposition or other health conditions known to predispose them to cancer.
Eighty Percent of Young Patients Receive Stage 3 or Stage 4 Diagnoses
The research demonstrated that eighty percent of the adolescent patients in the cohort were not diagnosed until their cancer had reached Stage 3 or Stage 4, meaning the disease had spread. Gizmodo.com reported that 51% of patients presented with Stage 3 tumors and 29% presented with Stage 4 tumors. This late-stage detection mirrors the experience of Jo Henderson, whose cancer had metastasized to her ovaries by the time physicians identified the source of her symptoms.
Once colorectal cancer spreads, treatment becomes significantly more complex. The study revealed that approximately 37% of the young patients experienced a cancer recurrence following treatment, and 45% of the patients died by the end of the study period. For comparison, the overall five-year survival rate for colorectal cancer across all age groups stands at 63%, highlighting the severe nature of the pediatric form of the disease.
Vague Symptoms Lead to Diagnostic Delays in Young Patients
Diagnosing colorectal cancer in teenagers presents distinct clinical challenges because patients are decades younger than the recommended age for routine colonoscopy screenings. Dr. Danielle Cameron noted that the symptoms reported by adolescents are frequently vague and overlap with far more common gastrointestinal ailments. According to nbcnews.com, approximately 74% of study participants reported back or abdominal pain, 45% experienced changes in bowel habits, a similar proportion noted unexplained weight loss, and 32% reported rectal bleeding.
Dr. Tara Henderson, chair of the department of pediatrics at the Yale School of Medicine, explained that numerous benign conditions cause identical warning signs.
Environmental Factors and Ultraprocessed Foods Under Investigation as Potential Triggers
Medical researchers continue to investigate the underlying causes driving the rising incidence of colorectal cancer among younger populations. Dr. Danielle Cameron suspects that childhood environmental exposures prompting DNA changes play a contributing role in the trend. Meanwhile, Dr. Kimmie Ng, director of the Young-Onset Colorectal Cancer Center at Dana-Farber Cancer Institute and Jo Henderson’s oncologist, pointed to the proliferation of ultraprocessed foods as a factor worthy of scrutiny. Ng noted prior research linking higher consumption of ultraprocessed foods in women to an elevated risk of colon polyps, which serve as precursors to cancer, while ongoing studies examine whether microplastics might also contribute to the disease.
A conventional risk factor for colorectal cancer involves having a first- or second-degree relative diagnosed with the disease. However, nbcnews.com reported that a family history of colorectal cancer was present in only 20% of the adolescents included in the study, showing that most of these early-onset cases occur sporadically.
Frequently Asked Questions About Adolescent Colorectal Cancer
How many adolescents are diagnosed with colorectal cancer each year in the United States?
According to nbcnews.com, colorectal cancer in individuals under the age of twenty is exceptionally rare, accounting for fewer than one hundred cases per year nationwide.
What were the most common symptoms reported by young patients in the study?
Data published by nbcnews.com shows that approximately 74% of patients experienced back or abdominal pain, 45% reported changes in bowel habits, a similar percentage noted unexplained weight loss, and 32% experienced rectal bleeding.
What percentage of patients in the pediatric study had a family history of the disease?
As reported by gizmodo.com, only about 20% of the adolescent and pediatric cases analyzed in the research had a family history of colorectal cancer.
What is the median age of patients identified in the pediatric oncology research?
According to gizmodo.com, the median age of the eighty-four patients diagnosed between 2012 and 2023 was 16.5 years, with symptoms persisting for a median duration of twelve weeks before diagnosis.
Worth a look